HomeCare, Yes please!
COVID-19 has caused a massive acceleration in the use of Telehealth and Remote Patient Monitoring. The time to act is now.
Telehealth, a quarter trillion dollar post Covid-19
The current crisis has demonstrated the relevance of telehealth and created an opening to modernize the care delivery system. A $3 billion revenue market has the potential to grow to $250 billion. Providers are seeing 50 to 175 times the number of patients via telehealth than they did before.
Homecare is Now.
We need greater accessibility to tools that allow us to personally assess our state of health now more than ever. In particular, the health of our lungs and overall respiratory function. MIR-Medical International Research is playing a key role in this picture, with very affordable solutions that enable the ability for our healthcare providers to manage their patients with Pulmonary-related issues remotely.
Who need Homecare spirometers
Quite a number of different stakeholders are now in need of products for Remote Patient Monitoring solutions, including National Health Services, Universities and Medical Centers, Patient Associations, Insurance Companies and more. The can finally integrate bluetooth based spirometers into their own software solutions, and take care of patient’s health remotely.
There are currently more than 100 hundred 3rd party Apps connected with MIR app-based spirometers and mainly are designed for Remote Patient Monitoring. Here are the direct links to some relevant articles already available on our website:
– The first respiratory telemedicine network in France
– Remote Patient Monitoring and Spirometry Gaming
– A complete remote solution including Videoconsulting
Here are the direct links to some relevant articles already available on our website:
– No clinically significant differences between Spirobank Smart and Lab based desktop systems
– Lung function variability in children and adolescents
– Effect On Asthma Control Using A Novel Digital Self-Management System